Cargando…
A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer
BACKGROUND: The high mortality of patients with non-small cell lung cancer (NSCLC) emphasizes the necessity of identifying a robust and reliable prognostic signature for NSCLC patients. This study aimed to identify and validate a prognostic signature for the prediction of both disease-free survival...
Autores principales: | Zuo, Shuguang, Wei, Min, Zhang, Hailin, Chen, Anxian, Wu, Junhua, Wei, Jiwu, Dong, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515678/ https://www.ncbi.nlm.nih.gov/pubmed/31088477 http://dx.doi.org/10.1186/s12967-019-1899-y |
Ejemplares similares
-
A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
por: He, Ru, et al.
Publicado: (2019) -
CD8(+) T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
por: Xu, Chun, et al.
Publicado: (2018) -
A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer
por: Zhao, Yue, et al.
Publicado: (2019) -
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
por: Meng, Gang, et al.
Publicado: (2019) -
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)